- Home
- NESR vs EXEL Comparison
NESR vs EXEL Comparison
Compare NESR & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NESR
- EXEL
- Stock Information
- Founded
- NESR 2017
- EXEL 1994
- Country
- NESR United States
- EXEL United States
- Employees
- NESR N/A
- EXEL N/A
- Industry
- NESR
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NESR
- EXEL Health Care
- Exchange
- NESR NYSE
- EXEL Nasdaq
- Market Cap
- NESR 565.7M
- EXEL 9.8B
- IPO Year
- NESR N/A
- EXEL 2000
- Fundamental
- Price
- NESR $6.40
- EXEL $38.55
- Analyst Decision
- NESR Strong Buy
- EXEL Buy
- Analyst Count
- NESR 4
- EXEL 18
- Target Price
- NESR $15.00
- EXEL $37.59
- AVG Volume (30 Days)
- NESR 386.2K
- EXEL 2.4M
- Earning Date
- NESR 03-12-2025
- EXEL 05-09-2025
- Dividend Yield
- NESR N/A
- EXEL N/A
- EPS Growth
- NESR 514.84
- EXEL 170.77
- EPS
- NESR 0.80
- EXEL 1.76
- Revenue
- NESR $1,301,704,000.00
- EXEL $2,168,701,000.00
- Revenue This Year
- NESR $9.40
- EXEL $5.78
- Revenue Next Year
- NESR $8.57
- EXEL $10.94
- P/E Ratio
- NESR $7.94
- EXEL $21.91
- Revenue Growth
- NESR 13.60
- EXEL 18.50
- 52 Week Low
- NESR $5.20
- EXEL $20.14
- 52 Week High
- NESR $9.89
- EXEL $40.02
- Technical
- Relative Strength Index (RSI)
- NESR N/A
- EXEL 63.64
- Support Level
- NESR N/A
- EXEL $35.34
- Resistance Level
- NESR N/A
- EXEL $37.67
- Average True Range (ATR)
- NESR 0.00
- EXEL 1.17
- MACD
- NESR 0.00
- EXEL 0.34
- Stochastic Oscillator
- NESR 0.00
- EXEL 96.71
About NESR NATIONAL ENERGY SVCS REUNITED CORP
National Energy Services Reunited Corp is a British Virgin Islands-based company engaged in providing products and services to the oil and gas industry in the Middle East and North Africa and the Asia Pacific regions. The company has two reportable segments: Production Services including coil tubing, stimulation, and pumping, nitrogen services, completions, pipelines, cementing, laboratory services and filtration services; and Drilling and Evaluation Services including drilling and workover rigs, rig services, services, and well-testing services among others. Revenues are majorly derived from production services of an oil or natural gas well. It derives maximum revenue from Production services segment.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.